Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4547472
Max Phase: Preclinical
Molecular Formula: C40H67N5O27
Molecular Weight: 1049.98
Molecule Type: Unknown
Associated Items:
ID: ALA4547472
Max Phase: Preclinical
Molecular Formula: C40H67N5O27
Molecular Weight: 1049.98
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@@](OC[C@H]2O[C@@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](OCCCCCCN=[N+]=[N-])O[C@@H]3CO)[C@H](O)[C@@H](O[C@]3(C(=O)O)C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O3)[C@H]2O)(C(=O)O)C[C@@H]1O
Standard InChI: InChI=1S/C40H67N5O27/c1-15(49)43-23-17(51)9-39(37(61)62,70-32(23)25(55)19(53)11-46)66-14-22-27(57)34(72-40(38(63)64)10-18(52)24(44-16(2)50)33(71-40)26(56)20(54)12-47)30(60)36(68-22)69-31-21(13-48)67-35(29(59)28(31)58)65-8-6-4-3-5-7-42-45-41/h17-36,46-48,51-60H,3-14H2,1-2H3,(H,43,49)(H,44,50)(H,61,62)(H,63,64)/t17-,18-,19+,20+,21+,22+,23+,24+,25+,26+,27-,28+,29+,30+,31+,32+,33+,34-,35+,36-,39+,40-/m0/s1
Standard InChI Key: IDVYIGLJVHKPEN-ZEWJJOHHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1049.98 | Molecular Weight (Monoisotopic): 1049.4023 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Wu HR, Anwar MT, Fan CY, Low PY, Angata T, Lin CC.. (2019) Expedient assembly of Oligo-LacNAcs by a sugar nucleotide regeneration system: Finding the role of tandem LacNAc and sialic acid position towards siglec binding., 180 [PMID:31351394] [10.1016/j.ejmech.2019.07.046] |
Source(1):